Mebeverine Hydrochloride Aspire Pharma (Mebeverine Hydrochloride)

The drug relaxes smooth muscle in the gastrointestinal tract by inhibiting calcium influx and modulating muscarinic receptors, which reduces the intensity of spasms and associated pain without impairing normal peristalsis.

The dosage of Mebeverine Hydrochloride is determined by the prescribing clinician based on the patient’s condition, severity of symptoms and individual response. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety of Mebeverine Hydrochloride in pregnancy and lactation has not been conclusively established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other antispasmodics such as hyoscine or dicyclomine, Mebeverine has a more selective action on gastrointestinal smooth muscle and a lower incidence of anticholinergic side effects like dry mouth and blurred vision, making it a preferred option for many patients with IBS.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture, heat and direct sunlight to maintain stability and potency.

Mebeverine Hydrochloride is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, significant drops in blood pressure, persistent tachycardia, hepatic dysfunction and severe skin reactions like Stevens‑Johnson syndrome. Immediate medical attention is required if any of these occur.

Patients with known hypersensitivity to mebeverine or any of its excipients should avoid the drug. Caution is also advised for individuals with severe hepatic or renal impairment, uncontrolled cardiovascular disease, or those taking medications that may cause dangerous interactions.